Form 6K Opthea Ltd For: 12 November
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ceryvyn Therapeutics Ltd (CYV)
The Ceryvyn share price today is 0.01, view ASX CYV stock exchange data. Track the latest Ceryvyn share price with real-time updates on CYV stock performance including market cap, day range, 52-week range and dividend yield. Access CYV charts, earnings dates and analyst estimates to support your investment decisions.
0.01
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.01
0.01
52 wk Range
0.01
0.03
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.010.01
52 wk Range
0.010.03
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CYV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Optiva Inc. Announces Results of Annual Meeting- Investing.com
Form 6K Opthea Ltd For: 31 October- Investing.com
- Form 6K Opthea Ltd For: 27 October
- Investing.com
- Form 6K Opthea Ltd For: 12 November
- Investing.com
- Form 6K Opthea Ltd For: 31 October
- Investing.com
- Form 6K Opthea Ltd For: 27 October
- Investing.com
- Form 6K Opthea Ltd For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Earnings
Latest Release
31-08-2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
Compare CYV to Peers and Sector
Metrics to compare | CYV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.9x | −0.4x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.5x | 3.9x | 2.6x | |
Price / LTM Sales | 13,679.8x | 10.6x | 3.1x | |
Upside (Analyst Target) | - | 105.9% | 52.9% | |
Fair Value Upside | Unlock | 6.9% | 6.4% | Unlock |
Ceryvyn Therapeutics Limited, a biopharmaceutical company, develops biologic therapy for the rare disease lymphangioleiomyomatosis in Australia. The company offers CYV-101, which is in pre-clinical trial stage, an inhaled therapy intended for delivery directly to the lung. It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Hawthorn East, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Ceryvyn (CYV) Share Price Today?
The Ceryvyn share price today is 0.01.
What is the current Ceryvyn (CYV) share price and day range?
As of 23-09-2026, the Ceryvyn share price is 0.01, with a previous close of 0.01. The share price has ranged from 0.01 to 0.01 today, while the 52-week range spans from 0.01 to 0.03.
What Is the Ceryvyn Market Cap?
As of today, Ceryvyn market cap is 13.68M.
What Is the Ceryvyn (CYV) Share Price Target?
The average 12-month share price target for Ceryvyn is 0.10, with a high estimate of 0.1 and a low estimate of 0.1. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +900.00% Upside potential.
What Is Ceryvyn's Earnings Per Share (TTM)?
The Ceryvyn EPS (TTM) is 0.24.
From a Technical Analysis Perspective, Is CYV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Ceryvyn Trade On?
Ceryvyn is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Ceryvyn?
The stock symbol for Ceryvyn is "CYV."
How Many Times Has Ceryvyn Stock Split?
Ceryvyn has split 1 times.
How Many Employees Does Ceryvyn Have?
Ceryvyn has 33 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.